Okey Stephanie sold CRNX
March 3, 2026 · Form 4 insider transaction
Okey Stephanie sold 3,000 shares of Crinetics Pharmaceuticals, Inc. at $39.67 per share, a transaction worth $119.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$39.67
Total value
$119.0K
InsiderOkey Stephanie
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 3, 2026
Filing dateMarch 4, 2026
Shares owned after13,300
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $39.67 per share.